340B program expansion and compliance concerns are leading drug manufacturers to take actions that impact program operation. Some have chosen to request comprehensive claims data from contract pharmacies and covered entities to enable manufacturer-led audits; others are eliminating the ability to receive a 340B price on contract pharmacy dispenses.
Kalderos 340B Pay, which uses a rebate model, is an alternative solution that solves compliance challenges while supporting the needs of all 340B stakeholders. This document highlights how implementing Kalderos 340B Pay will impact manufacturers, covered entities, contract pharmacies and most importantly, patients.
Download our whitepaper below to learn more.